# Lymphatic Filariasis (Elephantiasis): Causes & Treatment
> Explore the transmission, symptoms, risk factors, and WHO elimination strategies for Lymphatic Filariasis and Elephantiasis in this medical overview.

Tags: elephantiasis, lymphatic-filariasis, tropical-disease, mosquito-borne-diseases, public-health, epidemiology
## Slide 1: Elephantiasis Overview
Comprehensive guide to Lymphatic Filariasis covering transmission, symptoms, treatment, and epidemiology.

## Slide 2: Disease Transmission
* Caused by parasitic worms: *Wuchereria bancrofti* (90% of cases), *Brugia malayi*, and *Brugia timori*.
* Transmitted exclusively via mosquito bites (Culex, Anopheles, Aedes, Mansonia).
* Microfilariae exhibit nocturnal periodicity, peaking in the bloodstream at night.

## Slide 3: Incubation and Progression
* Long-term timeline: Larvae develop in 10-14 days; worms mature in 3-12 months.
* ~66% of cases are asymptomatic despite hidden lymphatic damage.
* Adult worms live 5-8 years inside the host.

## Slide 4: Clinical Symptoms
* Phase 1: Asymptomatic (hidden damage).
* Phase 2: Acute symptoms including fever, lymphangitis, and pain lasting 4-7 days.
* Phase 3: Chronic conditions like lymphedema, elephantiasis, and hydrocele.

## Slide 5: Vulnerability and Risk Factors
* Endemic regions: Sub-Saharan Africa, Southeast Asia, and parts of South America.
* Poverty-related factors: Lack of bed nets, poor sanitation, and limited preventive treatment (MDA).

## Slide 6: Complications
* Affects millions: ~25 million men with hydrocele; ~15 million people with lymphedema.
* Severe psychosocial impact due to stigma and disability.

## Slide 7: Treatment & Management
* Antiparasitic drugs: Diethylcarbamazine (DEC), Ivermectin, and Albendazole.
* Morbidity management: Limb hygiene protocol and surgical hydrocelectomy.

## Slide 8: Control Programs
* WHO Global Programme to Eliminate Lymphatic Filariasis (GPELF).
* Goal: Elimination by 2030 through Mass Drug Administration (MDA).
* Over 9.7 billion treatments delivered since 2000.

## Slide 9: Epidemiology Data
* Current status: 657 million people in 39 countries require preventive chemotherapy.
* 36 million people suffer from chronic manifestations.

## Slide 10: Pathogen Characteristics
* *Wuchereria bancrofti* adult worms are thread-like, 4–10 cm long.
* Microfilariae are approximately 250 μm.
---
This presentation was created with [Bobr AI](https://bobr.ai) — an AI presentation generator.